Federal Register / Vol. 74, No. 111 / Thursday, June 11, 2009 / Notices 27801 

The Secretary’s Advisory Committee on 

National Health Promotion and Disease 

Prevention Objectives for 2020 will 

address efforts to develop the nation’s 

health promotion and disease 

prevention objectives and strategies to 

improve the health status and reduce 

health risks for Americans by the year 

2020. The Committee will provide to the 

Secretary of Health and Human Services 

advice and consultation for developing 

and implementing the next iteration of 

national health promotion and disease 

prevention goals and objectives and 

provide recommendations for initiatives 

to occur during the initial 

implementation phase of the goals and 

objectives. HHS will use the 

recommendations to inform the 

development of the national health 

promotion and disease prevention 

objectives for 2020 and the process for 

implementing the objectives. The intent 

is to develop and launch objectives 

designed to improve the health status 

and reduce health risks for Americans 

by the year 2020. 

DATES: The Committee will meet on July 

10, 2009 from 2 p.m. to 4 p.m. Eastern 

Daylight Time (EDT). 

ADDRESSES: The meeting will be held 

online, via WebEx software. For detailed 

instructions about how to make sure 

that your windows computer and 

browser is set up for WebEx, please visit 

the ‘‘Secretary’s Advisory Committee’’ 

Web page of the Healthy People Web 

site at: http://www.healthypeople.gov/ 

hp2020/advisory/default.asp 

FOR FURTHER INFORMATION CONTACT: 

Emmeline Ochiai, Designated Federal 

Officer, Secretary’s Advisory Committee 

on National Health Promotion and 

Disease Prevention Objectives for 2020, 

U.S. Department of Health and Human 

Services, Office of Public Health and 

Science, Office of Disease Prevention 

and Health Promotion, 1101 Wootton 

Parkway, Room LL–100, Rockville, MD 

20852, (240) 453–8259 (telephone), 

(240) 453–8281 (fax). Additional 

information is available on the Internet 

at http://www.healthypeople.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose of Meeting: Every 10 years, 

through the Healthy People initiative, 

HHS leverages scientific insights and 

lessons from the past decade, along with 

the new knowledge of current data, 

trends, and innovations to develop the 

next iteration of national health 

promotion and disease prevention 

objectives. Healthy People provides 

science-based, 10-year national 

objectives for promoting health and 

preventing disease. Since 1979, Healthy 

People has set and monitored national 

health objectives to meet a broad range 

of health needs, encourage 

collaborations across sectors, guide 

individuals toward making informed 

health decisions, and measure the 

impact of our prevention and health 

promotion activities. Healthy People 

2020 will reflect assessments of major 

risks to health and wellness, changing 

public health priorities, and emerging 

issues related to our nation’s health 

preparedness and prevention. 

Public Participation at Meeting: 

Members of the public are invited to 

listen to the online Committee meeting. 

There will be no opportunity for oral 

public comments during the online 

Committee meeting. Written comments, 

however, are welcome throughout the 

development process of the national 

health promotion and disease 

prevention objectives for 2020. They can 

be submitted through the Healthy 

People Web site at: http:// 

www.healthypeople.gov/hp2020/ 

comments/ or they can be e-mailed to 

HP2020@hhs.gov. Please note that the 

public comment Web site will be 

updated throughout the Healthy People 

development process, so people should 

return to the site frequently and provide 

their input. 

To listen to the Committee meeting, 

individuals must pre-register to attend 

at the Healthy People Web site located 

at http://www.healthypeople.gov. 

Participation in the meeting is limited. 

Registrations will be accepted until 

maximum WebEx capacity is reached 

and must be completed by 9 a.m. EDT 

on July 10, 2009. A waiting list will be 

maintained should registrations exceed 

WebEx capacity. Individuals on the 

waiting list will be contacted as 

additional space for the meeting 

becomes available. 

Registration questions may be 

directed to Hilary Scherer at 

HP2020@norc.org (e-mail), (301) 634– 

9374 (phone) or (301) 634–9301 (fax). 

Dated: June 5, 2009. 

Penelope Slade-Sawyer, 

RADM, USPHS, Deputy Assistant Secretary 

for Health (Disease Prevention and Health 

Promotion). 

[FR Doc. E9–13635 Filed 6–10–09; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Proposed Projects 

Title: Native Employment Works 

(NEW) Program Plan Guidance and 

Report Requirements. 

OMB No.: 0970–0174. 

Description: The Native Employment 

Works (NEW) program plan is the 

application for NEW program funding. 

As approved by the Department of 

Health and Human Services (HHS), it 

documents how the grantee will carry 

out its NEW program. The NEW 

program plan guidance provides 

instructions for preparing a NEW 

program plan and explains the process 

for plan submission every third year. 

The NEW program report provides 

information on the activities and 

accomplishments of grantees’ NEW 

programs. The NEW program report and 

instructions specify the program data 

that NEW grantees report annually. 

Respondents: Federally recognized 

Indian Tribes and Tribal organizations 

that are NEW program grantees. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

NEW program plan guidance .......................................................................... 26 1 29 754 

NEW program report ....................................................................................... 48 1 15 720 

Estimated Total Annual Burden 

Hours: 1,474. 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 


jlentini on PROD1PC65 with NOTICES
27802 Federal Register / Vol. 74, No. 111 / Thursday, June 11, 2009 / Notices 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: June 8, 2009. 

Janean Chambers, 

Reports Clearance Officer. 

[FR Doc. E9–13684 Filed 6–10–09; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–N–0572] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Implementation of 

the Animal Generic Drug User Fee Act 

of 2008; User Fee Cover Sheet Form 

FDA 3728 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995 

(the PRA). 

DATES: Fax written comments on the 

collection of information by July 13, 

2009. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–6974, or e-mailed to 

oira_submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0632. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: 

Denver Presley Jr., Office of Information 

Management (HFA–710), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–796–3793. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Implementation of the Animal Generic 

Drug User Fee Act of 2008; User Fee 

Cover Sheet Form FDA 3728—21 U.S.C. 

379j-21 (OMB Control Number 0910– 

0632)—Extension 

This collection of information is 

currently approved under the 

emergency processing provisions of the 

PRA for 180 days. FDA is now seeking 

a 3-year clearance. 

Section 741 of the act (21 U.S.C. 379j21), establishes three different kinds of 

user fees: (1) Fees for certain types of 

abbreviated applications for generic new 

animal drugs, (2) annual fees for certain 

generic new animal drug products, and 

(3) annual fees for certain sponsors of 

abbreviated applications for generic new 

animal drugs and/or investigational 

submissions for generic new animal 

drugs. Because the submission of user 

fees concurrently with applications is 

required, the review of an application 

cannot begin until the fee is submitted. 

Form FDA 3728, the Animal Generic 

Drug User Fee Cover Sheet, is designed 

to provide the minimum necessary 

information in order to do the following: 

(1) Determine whether a fee is required 

for review of an application, (2) 

determine the amount of fee required, 

and (3) account for and track user fees. 

In the Federal Register of March 11, 

2009 (74 FR 10596), FDA published a 

60-day notice requesting public 

comment on the information collection 

provisions. No comments were received. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1

21 U.S.C. 

379j-21 No. of Respondents Annual Frequency per Response Total Annual Responses Hours per Response Total Hours 

Form FDA 

3728 20 2 40 .08 3.2 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Respondents to this collection of 

information are generic animal drug 

applicants. Based on FDA’s database 

system, there are an estimated 20 

sponsors of new animal drugs 

potentially subject to the Animal 

Generic Drug User Fee Act of 2008. 

Dated: June 3, 2009. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E9–13716 Filed 6–10–09; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Performance Progress Report. 

OMB No.: 0970–0334. 


jlentini on PROD1PC65 with NOTICES